GLP-1 drugs linked to lower risk of serious heart-related complications and infections after surgery
GLP-1 medications, widely prescribed for diabetes and weight loss, may also help protect people from serious complications after surgery. People taking GLP-1 medications had lower rates of major heart-related complications and infections after surgery than those not taking the drugs, according to results of a study of more than 2 million adults undergoing surgery presented at the ANESTHESIOLOGY…
Researchers have found that individuals taking GLP-1 medications, commonly prescribed for diabetes and weight loss, have a reduced risk of serious heart complications and infections following surgery. A study analyzing data from over 2 million adults undergoing surgery between 2016 and 2024 revealed that those taking GLP-1 drugs had an 11% lower likelihood of major cardiovascular issues, such as heart attack or stroke, and an 8% lower chance of postoperative infections, including surgical site infections and pneumonia.
Dr. Josephine Tolan, the lead study author and anesthesiologist, noted that while the findings are promising, further research is needed to confirm whether the medications themselves contribute to these benefits. GLP-1 medications may lower the risk of heart complications because they promote weight loss, improve blood pressure and blood sugar control, reduce inflammation, and potentially protect heart muscle during stress.
They may also help prevent infections by enhancing glucose control. However, the study's observational nature means it cannot establish a direct cause-and-effect relationship, and other factors could have played a role in the observed differences.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
